Future Directions in Colon Cancer

• New preventive agents

  • cylco-oxygenase inhibitors
    • Jacoby at Wisconsin: mouse FAP model

• Enhanced screening programs

  • virtual colonoscopy

• Impact of genetic testing

• Combinations of new chemotherapy agents

  • selection dictated by biomarkers

• Vaccine therapy

Previous slide

Back to first slide

View graphic version